Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2019-07-25 Legal Proceedings Report
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Date du délibéré du Tribunal de commerce prorogée au 2 août 2019
Legal Proceedings Report Classification · 99% confidence The document is a press release dated July 25, 2019, concerning a legal proceeding involving the company Zigi Capital S.A. (Europlasma group). Specifically, it announces the extension of the deliberation date by the Commercial Court (Tribunal de commerce) regarding a continuation plan. This content directly relates to significant lawsuits or regulatory actions affecting the company's status, which aligns best with the 'Legal Proceedings Report' definition (LTR). It is not an earnings release, an annual report, or a general regulatory filing (RNS), as it details a specific legal development.
2019-07-25 French
EUROPLASMA: CONVERSION D'OCABSA PAR ZIGI CAPITAL POUR UN MONTANT NOMINAL TOTAL DE 2 MILLIONS D'EUROS
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 19, 2019, announcing the conversion of convertible bonds (OCA) by Zigi Capital, resulting in a significant change in shareholding (Zigi Capital now holds about 10% of the capital). This event directly relates to changes in the company's capital structure and significant ownership levels. While it involves a capital change (SHA) and a major shareholding notification (MRQ), the core event described is a financing/capital structure transaction (conversion of debt into equity). Given the options, 'Capital/Financing Update' (CAP) is the most appropriate fit for detailing the outcome of a structured financing agreement (OCA conversion). It is not a general earnings release (ER), an annual report (10-K), or a simple notice of dividend (DIV).
2019-07-19 French
EUROPLASMA: audience du 16/07/2019 au Tribunal de commerce: délibéré fin juillet
Legal Proceedings Report Classification · 99% confidence The document is a press release dated July 18, 2019, concerning a legal proceeding involving the company EUROPLASMA and Zigi Capital S.A. Specifically, it discusses the status of a hearing before the Commercial Court (Tribunal de commerce) regarding a continuation plan and the court's decision being reserved until the end of July. This content directly relates to significant lawsuits or regulatory actions involving the company. Therefore, it fits the definition of a Legal Proceedings Report (LTR). It is not an earnings release, annual report, or a simple announcement of a report publication.
2019-07-18 French
EUROPLASMA: Information relative au nombre de droits de vote et d'actions composant le capital au 30/06/2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated July 3, 2019, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 30 juin 2019" (Information relative to the total number of voting rights and shares comprising the capital as of June 30, 2019). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of mandatory disclosure regarding the capital structure and voting rights is a specific regulatory filing, but among the provided codes, it most closely aligns with a general regulatory announcement or a specific capital/share structure update. Since it details the total number of shares and voting rights, it relates to the capital structure. However, it is not a general share issue (SHA) or a transaction in own shares (POS), but rather a periodic disclosure of the existing structure. Given the options, this mandatory disclosure of the total number of shares and voting rights is a specific type of regulatory filing. It is not an earnings release (ER), interim report (IR), or a management report (MDA). It is a formal declaration of the capital structure as of a specific date. This fits best under the general 'Regulatory Filings' (RNS) as a fallback, or potentially 'Share Issue/Capital Change' (SHA) if interpreted broadly, but RNS is safer for mandatory periodic disclosures not covered elsewhere. Upon review, there is no specific code for 'Total Voting Rights Disclosure'. Since it is a formal, mandatory disclosure concerning the share capital base, and not a transaction (SHA/POS), RNS is the most appropriate general regulatory category.
2019-07-03 French
EUROPLASMA: Premières mesures en vue de permettre la mise en place du plan de continuation
Regulatory Filings Classification · 99% confidence The document is a press release dated June 24, 2019, detailing significant corporate actions related to a 'plan de continuation' (continuation plan) following a court observation period. Key elements include changes in governance (new CEO/Board members), industrial restructuring plans (investments in production units), and multiple financing activities involving convertible bonds (OCABSA) with Zigi Capital and EHGOSF. It also announces the convocation of an Extraordinary General Meeting (EGM) on August 20, 2019, and the resumption of stock trading. Since the document announces significant capital structure changes, financing activities, and governance shifts, it strongly aligns with a Capital/Financing Update (CAP). While it mentions governance changes (MANG) and an upcoming shareholder meeting (which might relate to PSI or DVA), the primary focus is on securing financing and restructuring capital to implement the continuation plan. It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). Given the heavy emphasis on new debt/equity instruments and capital restructuring, CAP is the most appropriate primary classification.
2019-06-24 French
EUROPLASMA: Information relative au nombre d'actions composant le capital et des droits de vote au 31/05/2019
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated June 13, 2019, titled 'Information relative au nombre total de droits de vote et d'actions composant le capital au 31 mai 2019' (Information relative to the total number of voting rights and shares comprising the capital as of May 31, 2019). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of mandatory disclosure regarding the total number of shares and voting rights is typically classified as a regulatory filing or a specific capital/share structure update. Given the options, this is a direct notification about the capital structure and voting rights, which is a specific type of regulatory disclosure. It is not a general earnings release (ER), an interim report (IR), or a major shareholding notification (MRQ) which usually concerns changes by external parties crossing thresholds. It is most closely aligned with a general regulatory filing (RNS) or a specific capital structure announcement. Since it details the total number of shares and voting rights, which is a fundamental component of share structure reporting, and it is a short, mandatory disclosure, 'RNS' (Regulatory Filings) serves as the best general fit for mandatory, non-periodic regulatory updates that don't fit other specific categories like DIV or SHA (which usually implies issuance/buyback). However, since it is a direct report on the capital structure components (shares and votes), it is a specific regulatory disclosure. Given the provided definitions, 'RNS' is the most appropriate fallback for mandatory, non-periodic regulatory updates that don't fit elsewhere, although 'SHA' relates to share issues. Since this is a static count disclosure, RNS is safer than SHA.
2019-06-13 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.